|
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Official Patient Website
ENHERTU is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU is a prescription medicine used to treat adults who have non-small cell lung cancer (NSCLC) that has a certain mutation in the HER2 gene and cannot be removed by surgery or has spread to other parts of your body (metastatic), and who have received a prior treatment
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU is a prescription medicine used to treat adults who have human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
- HER2-positive mBC ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Find information about HER2-positive mBC, how ENHERTU® (fam-trastuzumab deruxtecan-nxki) is thought to work, and how you will receive it See the full Important Safety Information, Prescribing Information, including Boxed WARNINGS, and Medication Guide for more information
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-low breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior chemotherapy
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Potential Side Effects
ENHERTU is a prescription medicine used to treat adults who have human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
- About ENHERTU | ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Advanced . . .
ENHERTU is a prescription medicine used to treat adults who have stomach cancer called gastric or GEJ adenocarcinoma that is HER2-positive and has spread to areas near your stomach (locally advanced) or that has spread to other parts of your body (metastatic), and who have received a prior trastuzumab-based regimen
- Results with ENHERTU® (fam-trastuzumab deruxtecan-nxki)
ENHERTU is a prescription medicine used to treat adults who have non-small cell lung cancer (NSCLC) that has a certain mutation in the HER2 gene and cannot be removed by surgery or has spread to other parts of your body (metastatic), and who have received a prior treatment
|
|
|